Company registration number 13062468 (England and Wales)
BASIS RESEARCH GROUP LIMITED
ANNUAL REPORT AND FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
BASIS RESEARCH GROUP LIMITED
COMPANY INFORMATION
Directors
Mr R Mortensen
Mrs C A Smith
Company number
13062468
Registered office
264 Banbury Road
Oxford
OX2 7DY
Auditor
Shaw Gibbs (Audit) Limited
264 Banbury Road
Oxford
OX2 7DY
BASIS RESEARCH GROUP LIMITED
CONTENTS
Page
Strategic report
1 - 2
Directors' report
3 - 4
Independent auditor's report
5 - 7
Statement of comprehensive income
8
Balance sheet
9
Statement of changes in equity
10
Notes to the financial statements
11 - 18
BASIS RESEARCH GROUP LIMITED
STRATEGIC REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 1 -

The directors present the strategic report for the year ended 31 March 2025.

Review of the business

The Company acts as the holding company for Basis Research Limited, the main UK trading entity within the Basis Research Group ("Group"), among other Basis companies. The Company's investment remains reasonable, with strong performance during the year. At the reporting date, the Company had net assets of £1,775,388 (2024: £1,789,290).

Strategy

The Group companies continues to explore expansion of its global presence and market share with continued investment in its emerging US entities. This continues to facilitate organic and new business growth for the Group in addition to creating opportunities of cross-sell for the Company. A specific area of focus for investment continues to be in building AI solutions that both disrupt the AI industry in addition to streamlining our mainstream operations. The Group continues to strive to be at the forefront of the technological advancement for our industry in this exciting space.

The Group has exciting plans to accelerate future growth with further investment in marketing activities committed tocontinue to cement the Basis Research brand as a leading choice for market research services globally.

The Group is multi award winning – in addition to being named Quirk’s 2024 Marketing Research Supplier of the Year, Basis Global’s success was recognised with a record 8 nominations at the 2025 MRS Awards — more than any other insight consultancy — and 5 wins, including:

- Business Impact of the Year – Global (with EuroMillions)

- Healthcare Research (with UKHSA)

- New Consumer Insight (with Which?)

- B2B Research (with Sage)

- Social Impact (Liz Nelson Award with UKHSA)

These awards reflect the ambition of our clients, the strength of our team, and the impact we’re able to deliver.

These ongoing, regular achievements are expected to continue to generate interest from prospective clients and talent alike.

Training and development

As a culture first business, the Company is heavily committed to investment in ongoing talent acquisition, training and retention as a firm method of ensuring consistent and optimal client delivery, this allows the business to maintain its excellent insight standards. Remuneration packages are regularly benchmarked to enable the business to continue to attract the very best calibre of talent.

Principal risks and uncertainties

The market research sector is predominantly ad-hoc and is always expected to remain uncertain however, the Company is very well established with a long standing, repeat client base. The commitment to delivering excellent customer experience along with the strategy of the Group detailed above is key to ongoing future proofing of the business and ensuring the Company can withstand any arising economic challenges that are faced by the industry.

The Group has a highly diversified client base with the majority of business relating to short-term projects as opposed to long-term retained contracts and so there is minimal reliance on individual clients.

The Company makes little use of financial instruments so its exposure to price risk, credit risk, liquidity risk and cash flow risk is not material for the assessment of the assets, liabilities and financial position of the company.

Development and performance

Based on the excellent growth the Company has realised during the last financial year along with the near-term uncertainties, we believe the Company is in a strong position at the year-end.

BASIS RESEARCH GROUP LIMITED
STRATEGIC REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 2 -
Key performance indicators

The company does not use key performance indicators. Basis Research Group Limited's key role is that of a holding company for other trading entities in the group, as well as to act as a UK base for the global Basis group.

Future developments and research and development

The future outlook for the Company remains strong, further growth is anticipated for 2025 as a result of the continued expansion of the Group, driving enhanced brand awareness globally.

The Company continues to uphold its excellent reputation by achieving outstanding levels of client satisfaction, cementing Basis Research Group as a leading choice for the provision of market research services.

On behalf of the board

Mr R Mortensen
Director
30 October 2025
BASIS RESEARCH GROUP LIMITED
DIRECTORS' REPORT
FOR THE YEAR ENDED 31 MARCH 2025
- 3 -

The directors present their annual report and financial statements for the year ended 31 March 2025.

Principal activities

The principal activity of the company continued to be that of a holding company.

Directors

The directors who held office during the year and up to the date of signature of the financial statements were as follows:

Mr R Mortensen
Mrs C A Smith
Auditor

The auditor, Shaw Gibbs (Audit) Limited, is deemed to be reappointed under section 487(2) of the Companies Act 2006.

Statement of directors' responsibilities

The directors are responsible for preparing the annual report and the financial statements in accordance with applicable law and regulations.

Company law requires the directors to prepare financial statements for each financial year. Under that law the directors have elected to prepare the financial statements in accordance with United Kingdom Generally Accepted Accounting Practice (United Kingdom Accounting Standards and applicable law). Under company law the directors must not approve the financial statements unless they are satisfied that they give a true and fair view of the state of affairs of the company and of the profit or loss of the company for that period. In preparing these financial statements, the directors are required to:

- select suitable accounting policies and then apply them consistently;

- make judgements and accounting estimates that are reasonable and prudent;

- state whether applicable UK Accounting Standards have been followed, subject to any material departures disclosed and explained in the financial statements; and

- prepare the financial statements on the going concern basis unless it is inappropriate to presume that the company will continue in business.

The directors are responsible for keeping adequate accounting records that are sufficient to show and explain the company’s transactions and disclose with reasonable accuracy at any time the financial position of the company and enable them to ensure that the financial statements comply with the Companies Act 2006. They are also responsible for safeguarding the assets of the company and hence for taking reasonable steps for the prevention and detection of fraud and other irregularities.

Statement of disclosure to auditor

So far as each person who was a director at the date of approving this report is aware, there is no relevant audit information of which the company’s auditor is unaware. Additionally, the directors individually have taken all the necessary steps that they ought to have taken as directors in order to make themselves aware of all relevant audit information and to establish that the company’s auditor is aware of that information.

Matters covered in the strategic report

The company has chosen in accordance with Companies Act 2006, s. 414C(11) to set out in the company's strategic report information required by Large and Medium-sized Companies and Groups (Accounts and Reports) Regulations 2008, Sch. 7 to be contained in the directors' report. It has done so in respect of a fair review of the business, developments and performance, and principal risks and uncertainties.

Medium-sized companies exemption

This report has been prepared in accordance with the provisions applicable to companies entitled to the medium-sized companies exemption.

BASIS RESEARCH GROUP LIMITED
DIRECTORS' REPORT (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 4 -
On behalf of the board
Mr R Mortensen
Director
30 October 2025
BASIS RESEARCH GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF BASIS RESEARCH GROUP LIMITED
- 5 -
Opinion

We have audited the financial statements of Basis Research Group Limited (the 'company') for the year ended 31 March 2025 which comprise the statement of comprehensive income, the balance sheet, the statement of changes in equity and notes to the financial statements, including significant accounting policies. The financial reporting framework that has been applied in their preparation is applicable law and United Kingdom Accounting Standards, including Financial Reporting Standard 102 The Financial Reporting Standard applicable in the UK and Republic of Ireland (United Kingdom Generally Accepted Accounting Practice).

In our opinion the financial statements:

- give a true and fair view of the state of the company's affairs as at 31 March 2025 and of its loss for the year then ended;

- have been properly prepared in accordance with United Kingdom Generally Accepted Accounting Practice; and

- have been prepared in accordance with the requirements of the Companies Act 2006.

Basis for opinion

We conducted our audit in accordance with International Standards on Auditing (UK) (ISAs (UK)) and applicable law. Our responsibilities under those standards are further described in the Auditor's responsibilities for the audit of the financial statements section of our report. We are independent of the company in accordance with the ethical requirements that are relevant to our audit of the financial statements in the UK, including the FRC’s Ethical Standard, and we have fulfilled our other ethical responsibilities in accordance with these requirements. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Conclusions relating to going concern

In auditing the financial statements, we have concluded that the directors' use of the going concern basis of accounting in the preparation of the financial statements is appropriate.

Based on the work we have performed, we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue.

Our responsibilities and the responsibilities of the directors with respect to going concern are described in the relevant sections of this report.

Other information

The other information comprises the information included in the annual report other than the financial statements and our auditor's report thereon. The directors are responsible for the other information contained within the annual report. Our opinion on the financial statements does not cover the other information and, except to the extent otherwise explicitly stated in our report, we do not express any form of assurance conclusion thereon. Our responsibility is to read the other information and, in doing so, consider whether the other information is materially inconsistent with the financial statements or our knowledge obtained in the course of the audit, or otherwise appears to be materially misstated. If we identify such material inconsistencies or apparent material misstatements, we are required to determine whether this gives rise to a material misstatement in the financial statements themselves. If, based on the work we have performed, we conclude that there is a material misstatement of this other information, we are required to report that fact.

We have nothing to report in this regard.

Opinions on other matters prescribed by the Companies Act 2006

In our opinion, based on the work undertaken in the course of our audit:

- the information given in the strategic report and the directors' r eport for the financial year for which the financial statements are prepared is consistent with the financial statements; and

- the strategic report and the directors' report have been prepared in accordance with applicable legal requirements.

BASIS RESEARCH GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF BASIS RESEARCH GROUP LIMITED (CONTINUED)
- 6 -
Matters on which we are required to report by exception

In the light of the knowledge and understanding of the company and its environment obtained in the course of the audit, we have not identifie d material misstatements in the strategic report or the directors' r eport.

We have nothing to report in respect of the following matters in relation to which the Companies Act 2006 requires us to report to you if, in our opinion:

- adequate accounting records have not been kept, or returns adequate for our audit have not been received from branches not visited by us; or

- the financial statements are not in agreement with the accounting records and returns; or

- certain disclosures of directors' remuneration specified by law are not made; or

- we have not received all the information and explanations we require for our audit.

Responsibilities of directors

As explained more fully in the directors' r esponsibilities s tatement, the directors are responsible for the preparation of the financial statements and for being satisfied that they give a true and fair view, and for such internal control as the directors determine is necessary to enable the preparation of financial statements that are free from material misstatement, whether due to fraud or error. In preparing the financial statements, the directors are responsible for assessing the company's ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting unless the directors either intend to liquidate the company or to cease operations, or have no realistic alternative but to do so.

Auditor's responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the financial statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor's report that includes our opinion. Reasonable assurance is a high level of assurance but is not a guarantee that an audit conducted in accordance with ISAs (UK) will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these financial statements.

Irregularities, including fraud, are instances of non-compliance with laws and regulations. We design procedures in line with our responsibilities, outlined above, to detect material misstatements in respect of irregularities, including fraud. The extent to which our procedures are capable of detecting irregularities, including fraud, is detailed below.

1. 1. At the planning stage of the audit, we gain an understanding of the laws and regulations which apply to the company and how the management seek to comply with those laws and regulations. This helps us to plan appropriate risk assessments.

2. 2. During the audit, we focus on relevant risk areas and review the compliance with the laws and regulations by making relevant enquiries and undertaking corroboration, for example by reviewing b oard m inutes and other documentation.

3. 3. We assess the risk of material misstatement in the financial statements including as a result of fraud and undert a k e procedures including:

   1. a. Reviewing the controls set in place by management;

   2. b. Making enquiries of management as to whether they consider fraud or other irregularity may have taken place, or where such opportunity might exist;

   3. c. Challenging management assumptions with regard to accounting estimates; and

   4. d. Identifying and testing journal entries, particularly those which appear to be unusual by size or nature.

Because of the inherent limitations of an audit, there is a risk that we will not detect all irregularities, including those leading to a material misstatement in the financial statements or non-compliance with regulation. This risk increases the more that compliance with a law or regulation is removed from the events and transactions reflected in the financial statements, as we will be less likely to become aware of instances of non-compliance. The risk is also greater regarding irregularities occurring due to fraud rather than error, as fraud involves intentional concealment, forgery, collusion, omission or misrepresentation.

BASIS RESEARCH GROUP LIMITED
INDEPENDENT AUDITOR'S REPORT
TO THE MEMBER OF BASIS RESEARCH GROUP LIMITED (CONTINUED)
- 7 -

A further description of our responsibilities is available on the Financial Reporting Council’s website at: https://www.frc.org.uk/auditorsresponsibilities. This description forms part of our auditor's report.

Use of our report

This report is made solely to the company's member in accordance with Chapter 3 of Part 16 of the Companies Act 2006. Our audit work has been undertaken so that we might state to the company's member those matters we are required to state to the member in an auditor's report and for no other purpose. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than the company and the company's member, for our audit work, for this report, or for the opinions we have formed.

Malik Nayyer Salim (Senior Statutory Auditor)
For and on behalf of Shaw Gibbs (Audit) Limited
264 Banbury Road
Oxford
OX2 7DY
30 October 2025
BASIS RESEARCH GROUP LIMITED
STATEMENT OF COMPREHENSIVE INCOME
FOR THE YEAR ENDED 31 MARCH 2025
- 8 -
2025
2024
Notes
£
£
Turnover
3
80,671
-
Cost of sales
(80,671)
-
Gross profit
-
-
Administrative expenses
(13,832)
(23,032)
Operating loss
4
(13,832)
(23,032)
Interest receivable and similar income
3
-
0
955,835
Loss on disposal of subsidiary
(70)
-
(Loss)/profit before taxation
(13,902)
932,803
Tax on (loss)/profit
7
-
0
-
0
(Loss)/profit for the financial year
(13,902)
932,803

The statement of comprehensive income has been prepared on the basis that all operations are continuing operations.

BASIS RESEARCH GROUP LIMITED
BALANCE SHEET
AS AT
31 MARCH 2025
31 March 2025
- 9 -
2025
2024
Notes
£
£
£
£
Fixed assets
Investments
9
1,170,083
1,170,153
Current assets
Debtors
11
450,834
885,454
Cash at bank and in hand
207,229
67,925
658,063
953,379
Creditors: amounts falling due within one year
12
(52,758)
(334,242)
Net current assets
605,305
619,137
Net assets
1,775,388
1,789,290
Capital and reserves
Called up share capital
13
1,656
1,656
Profit and loss reserves
1,773,732
1,787,634
Total equity
1,775,388
1,789,290

These financial statements have been prepared in accordance with the provisions relating to medium-sized companies.

The financial statements were approved by the board of directors and authorised for issue on 30 October 2025 and are signed on its behalf by:
Mr R Mortensen
Director
Company registration number 13062468 (England and Wales)
BASIS RESEARCH GROUP LIMITED
STATEMENT OF CHANGES IN EQUITY
FOR THE YEAR ENDED 31 MARCH 2025
- 10 -
Share capital
Profit and loss reserves
Total
Notes
£
£
£
Balance at 1 April 2023
1,656
1,234,831
1,236,487
Year ended 31 March 2024:
Profit and total comprehensive income
-
932,803
932,803
Dividends
8
-
(380,000)
(380,000)
Balance at 31 March 2024
1,656
1,787,634
1,789,290
Year ended 31 March 2025:
Loss and total comprehensive expense
-
(13,902)
(13,902)
Balance at 31 March 2025
1,656
1,773,732
1,775,388
BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 MARCH 2025
- 11 -
1
Accounting policies
Company information

Basis Research Group Limited is a private company limited by shares incorporated in England and Wales. The registered office is 264 Banbury Road, Oxford, OX2 7DY.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary a mounts in these financial statements are rounded to the nearest £1.

The financial statements have been prepared under the historical cost convention. The principal accounting policies adopted are set out below.

This company is a qualifying entity for the purposes of FRS 102, being a member of a group where the parent of that group prepares publicly available consolidated financial statements, including this company, which are intended to give a true and fair view of the assets, liabilities, financial position and profit or loss of the group. T he company has therefore taken advantage of e xemptions from the following disclosure requirements:

- Section 7 ‘Statement of Cash Flows’: Presentation of a statement of cash flow and related notes and disclosures;

- Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instrument Issues: Interest income/expense and net gains/losses for financial instruments not measured at fair value; basis of determining fair values; details of collateral, loan defaults or breaches, details of hedges, hedging fair value changes recognised in profit or loss and in other comprehensive income;

- Section 33 ‘Related Party Disclosures’: Compensation for key management personnel.

The company has taken advantage of the exemption under section 400 of the Companies Act 2006 not to prepare consolidated accounts. The financial statements present information about the company as an individual entity and not about its group.

Basis Research Group Limited is a wholly owned subsidiary of Basis Research Group Holdings Limited and the results of Basis Research Group Limited are included in the consolidated financial statements of Basis Research Group Holdings Limited which are available from 264 Banbury Road, Oxford, Oxfordshire, England, OX2 7DY.

1.2
Going concern

A true t the time of approving the financial statements, t he directors have a reasonable expectation that the company has adequate resources to continue in operational existence for the foreseeable future. Thus t he directors continue to adopt the going concern basis of accounting in preparing the financial statements.

1.3
Turnover

Revenue comprises sales of goods or services provided to customers net of value added tax and other sales taxes, less an appropriate deduction for actual and expected returns and discounts. Revenue is recognised when performance obligations are satisfied and the control of goods or services is transferred to the buyer. Where the performance obligation is satisfied over time, revenue is recognised in accordance with its progress towards complete satisfaction of that performance obligation.

1.4
Fixed asset investments

Interests in subsidiaries are initially measured at cost and subsequently measured at cost less any accumulated impairment losses. The investments are assessed for impairment at each reporting date and any impairment losses or reversals of impairment losses are recognised immediately in profit or loss.

BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 12 -

A subsidiary is an entity controlled by the company. Control is the power to govern the financial and operating policies of the entity so as to obtain benefits from its activities.

1.5
Cash and cash equivalents

Cash and cash equivalents are basic financial assets and include cash in hand, deposits held at call with banks, other short-term liquid investments with original maturities of three months or less, and bank overdrafts. Bank overdrafts are shown within borrowings in current liabilities.

1.6
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Impairment of financial assets

Financial assets, other than those held at fair value through profit and loss, are assessed for indicators of impairment at each reporting end date.

Financial assets are impaired where there is objective evidence that, as a result of one or more events that occurred after the initial recognition of the financial asset, the estimated future cash flows have been affected. If an asset is impaired, the impairment loss is the difference between the carrying amount and the present value of the estimated cash flows discounted at the asset’s original effective interest rate. The impairment loss is recognised in profit or loss.

If there is a decrease in the impairment loss arising from an event occurring after the impairment was

recognised, the impairment is reversed. The reversal is such that the current carrying amount does not

exceed what the carrying amount would have been, had the impairment not previously been recognised. The impairment reversal is recognised in profit or loss.

Derecognition of financial assets

Financial assets are derecognised only when the contractual rights to the cash flows from the asset expire or are settled, or when the group transfers the financial asset and substantially all the risks and rewards of ownership to another entity, or if some significant risks and rewards of ownership are retained but control of the asset has transferred to another party that is able to sell the asset in its entirety to an unrelated third party.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
1
Accounting policies
(Continued)
- 13 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future paymen ts discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. A m ounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

Derecognition of financial liabilities

Financial liabilities are derecognised when the group's contractual obligations expire or are discharged or cancelled.

1.7
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

1.8
Employee benefits

The costs of short-term employee benefits are recognised as a liability and an expense, unless those costs are required to be recognised as part of the cost of stock or fixed assets.

The cost of any unused holiday entitlement is recognised in the period in which the employee’s services are received.

Termination benefits are recognised immediately as an expense when the company is demonstrably committed to terminate the employment of an employee or to provide termination benefits.

1.9
Foreign exchange

Transactions in currencies other than pounds sterling are recorded at the rates of exchange prevailing at the dates of the transactions. At each reporting end date, monetary assets and liabilities that are denominated in foreign currencies are retranslated at the rates prevailing on the reporting end date. Gains and losses arising on translation in the period are included in profit or loss.

BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 14 -
2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

Critical judgements

The following judgements (apart from those involving estimates) have had the most significant effect on amounts recognised in the financial statements.

Impairment of investments

Management carry out a review of indicators of impairment in relation of investments in subsidiaries on an annual basis. In performing this review, management are required to make judgements as to whether the information considered (for example, recent results of the subsidiary) represents an indicator of impairment. Should indicators of impairment be noted, management then perform a detailed review of the value of the investments held in order to assess whether an impairment is required.

3
Turnover and other revenue
2025
2024
£
£
Turnover analysed by class of business
Project income
80,671
-
2025
2024
£
£
Turnover analysed by geographical market
Rest of the World
80,671
-
2025
2024
£
£
Other revenue
Dividends received from shares in group undertakings
-
955,835
4
Operating loss
2025
2024
Operating loss for the year is stated after charging:
£
£
Exchange losses
40
1,668
BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 15 -
5
Auditor's remuneration
2025
2024
Fees payable to the company's auditor and associates:
£
£
For audit services
Audit of the financial statements of the company
8,000
6,000
For other services
All other non-audit services
5,500
5,020
6
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Directors / Partners
2
2
7
Taxation

The actual charge for the year can be reconciled to the expected (credit)/charge for the year based on the profit or loss and the standard rate of tax as follows:

2025
2024
£
£
(Loss)/profit before taxation
(13,902)
932,803
Expected tax (credit)/charge based on the standard rate of corporation tax in the UK of 25.00% (2024: 25.00%)
(3,476)
233,201
Tax effect of expenses that are not deductible in determining taxable profit
18
2,605
Unutilised tax losses carried forward
3,458
-
0
Group relief
-
0
3,153
Dividend income
-
0
(238,959)
Taxation charge for the year
-
-
8
Dividends
2025
2024
£
£
Interim paid
-
0
380,000
BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 16 -
9
Fixed asset investments
2025
2024
Notes
£
£
Investments in subsidiaries
10
1,170,083
1,170,153
Movements in fixed asset investments
Shares in subsidiaries
£
Cost or valuation
At 1 April 2024
1,170,153
Disposals
(70)
At 31 March 2025
1,170,083
Carrying amount
At 31 March 2025
1,170,083
At 31 March 2024
1,170,153

On 30 March 2025, the company sold its 70% shareholding in Basis Social Limited for total deferred consideration of £612,010 as set out further in note 14.

10
Subsidiaries

Details of the company's subsidiaries at 31 March 2025 are as follows:

Name of undertaking
Address
Nature of business
Class of
% Held
shares held
Direct
Indirect
Basis Research Limited
1
Market Research
Ordinary
100.00
-
Basis Research LA LLC
2
Market Research
Ordinary
100.00
-
Basis US Inc
3
Holding Company
Ordinary
100.00
-
Basis New York LLC
3
Market Research
Ordinary
0
79.00
Basis Health London Limited
1
Market Research
Ordinary
74.00
-
Basis Chicago
4
Market Research
Ordinary
60.00
-
Basis Ideas LLC
3
Market Research
Ordinary
0
73.00

Registered office addresses:

1
264 Banbury Road, Oxford, Oxfordshire, England, OX2 7DY
2
6121 Sunset Boulevard, Los Angeles, CA 90028 USA
3
370 Lexington Avenue, Suite 2000, New York, NY 10017, USA
4
500 W. Madison Street, Suite 1000, Chicago, IL 60661, USA
BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
10
Subsidiaries
(Continued)
- 17 -

The company held 100% of the issued share capital in Basis Health London Limited at 31 March 2024. The subsidiary company then issued share capital during the current year and as a result the shareholding reduced to 74%.

As set out further in note 9, the company sold its 70% shareholding in Basis Social Limited during the year.

Also within the year, the shareholding in the following overseas companies changed accordingly:

Basis Research LA LLC increased up to 100% (2024: 90%); Basis Chicago decreased down to 6 0% (2024:

83%) and Basis Ideas LLC in creased up to 73% (2024: 65%).

11
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
39,759
-
0
Amounts owed by group undertakings
410,600
885,454
Other debtors
100
-
0
Prepayments and accrued income
375
-
0
450,834
885,454
12
Creditors: amounts falling due within one year
2025
2024
£
£
Amounts owed to group undertakings
39,758
329,742
Accruals and deferred income
13,000
4,500
52,758
334,242
13
Share capital
2025
2024
2025
2024
Ordinary share capital
Number
Number
£
£
Issued and fully paid
A Ordinary Shares of £1 each
500
500
500
500
B Ordinary Shares of £1 each
107
107
107
107
C, D, F and G Ordinary Shares of £1 each
4
4
4
4
H Ordinary Shares of £1 each
1,045
1,045
1,045
1,045
1,656
1,656
1,656
1,656
BASIS RESEARCH GROUP LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 MARCH 2025
- 18 -
14
Contingent asset consideration

As part of the disposal of Basis Social Limited on 30 March 2025, the company is entitled to deferred consideration of up to £612,010 from the purchaser.

The amount is payable in instalments from July 2026 onwards, subject to the availability of distributable profits in the acquired company, or earlier in the event of an exit or by the long-stop date. Interest will accrue on any outstanding balance from 1 July 2026 at a rate of 2% above Barclays Bank base rate.

Receipt of the deferred consideration is dependent on the future performance and cash flows of the acquired business, which are uncertain. Accordingly, at the reporting date, no asset has been recognised in the financial statements. The company will recognise income in future periods upon receipt of funds.

15
Events after the reporting date

After the year end, the company's subsidiary Basis US Inc. partially sold its ownership in the following subsidiary companies:

- Basis Ideas LLC, resulting in the company's indirect ownership reducing from 73% to 56%; and

- Basic New York LLC, resulting in the company's indirect ownership reducing from 79% to 51%.

16
Related party transactions

As a wholly owned subsidiary undertaking of Basis Research Group Holdings Limited, the company has taken advantage of the exemption in FRS 102 Section 33.1A and has not disclosed transactions and outstanding balances with entities which form part of the group, where they are 100% owned (directly or indirectly) by Basis Research Group Holdings Limited.

During the year, the company purchased services totalling £80,671 (2024: £nil) from Basis Chicago. At the year end, the company owed Basis Chicago £39,75 8 (2024: £n il). The balance is unsecured, interest free and repayable on demand. The related party is a company under common control.

17
Ultimate controlling party

The immediate and ultimate parent undertaking of the company is Basis Research Group Holdings Limited which owns 100% of the allotted share capital of the company.

The smallest and largest group of companies within which the company belongs and for which consolidated financial statements are prepared is that headed by Basis Research Group Holdings Limited. Group financial statements can be obtained from its registered office, 264 Banbury Road, Oxford, United Kingdom, OX2 7DY.

The ultimate controlling party is Rune Mortensen, by virtue of his majority shareholding in Basis Research Group Holdings Ltd.

2025-03-31 2024-04-01 false false false CCH Software CCH Accounts Production 2025.200 Mr R Mortensen Mrs C A Smith 13062468 2024-04-01 2025-03-31 13062468 bus:Director1 2024-04-01 2025-03-31 13062468 bus:Director2 2024-04-01 2025-03-31 13062468 bus:RegisteredOffice 2024-04-01 2025-03-31 13062468 2025-03-31 13062468 2023-04-01 2024-03-31 13062468 core:RetainedEarningsAccumulatedLosses 2023-04-01 2024-03-31 13062468 core:RetainedEarningsAccumulatedLosses 2024-04-01 2025-03-31 13062468 2024-03-31 13062468 core:ShareCapital 2025-03-31 13062468 core:ShareCapital 2024-03-31 13062468 core:RetainedEarningsAccumulatedLosses 2025-03-31 13062468 core:RetainedEarningsAccumulatedLosses 2024-03-31 13062468 core:ShareCapital 2023-03-31 13062468 core:RetainedEarningsAccumulatedLosses 2023-03-31 13062468 core:ShareCapitalOrdinaryShareClass1 2025-03-31 13062468 core:ShareCapitalOrdinaryShareClass1 2024-03-31 13062468 core:ShareCapitalOrdinaryShareClass2 2025-03-31 13062468 core:ShareCapitalOrdinaryShareClass2 2024-03-31 13062468 core:ShareCapitalOrdinaryShareClass3 2025-03-31 13062468 core:ShareCapitalOrdinaryShareClass3 2024-03-31 13062468 core:ShareCapitalOrdinaryShareClass4 2025-03-31 13062468 core:ShareCapitalOrdinaryShareClass4 2024-03-31 13062468 core:ShareCapitalOrdinaryShares 2025-03-31 13062468 core:ShareCapitalOrdinaryShares 2024-03-31 13062468 core:UKTax 2024-04-01 2025-03-31 13062468 core:UKTax 2023-04-01 2024-03-31 13062468 core:Non-currentFinancialInstruments 2025-03-31 13062468 core:Non-currentFinancialInstruments 2024-03-31 13062468 core:Subsidiary1 2024-04-01 2025-03-31 13062468 core:Subsidiary2 2024-04-01 2025-03-31 13062468 core:Subsidiary3 2024-04-01 2025-03-31 13062468 core:Subsidiary4 2024-04-01 2025-03-31 13062468 core:Subsidiary5 2024-04-01 2025-03-31 13062468 core:Subsidiary6 2024-04-01 2025-03-31 13062468 core:Subsidiary7 2024-04-01 2025-03-31 13062468 core:Subsidiary1 1 2024-04-01 2025-03-31 13062468 core:Subsidiary2 2 2024-04-01 2025-03-31 13062468 core:Subsidiary3 3 2024-04-01 2025-03-31 13062468 core:Subsidiary4 4 2024-04-01 2025-03-31 13062468 core:Subsidiary5 5 2024-04-01 2025-03-31 13062468 core:Subsidiary6 6 2024-04-01 2025-03-31 13062468 core:Subsidiary7 7 2024-04-01 2025-03-31 13062468 core:CurrentFinancialInstruments 2025-03-31 13062468 core:CurrentFinancialInstruments 2024-03-31 13062468 bus:OrdinaryShareClass1 2024-04-01 2025-03-31 13062468 bus:OrdinaryShareClass2 2024-04-01 2025-03-31 13062468 bus:OrdinaryShareClass3 2024-04-01 2025-03-31 13062468 bus:OrdinaryShareClass4 2024-04-01 2025-03-31 13062468 bus:OrdinaryShareClass1 2025-03-31 13062468 bus:OrdinaryShareClass1 2024-03-31 13062468 bus:OrdinaryShareClass2 2025-03-31 13062468 bus:OrdinaryShareClass2 2024-03-31 13062468 bus:OrdinaryShareClass3 2025-03-31 13062468 bus:OrdinaryShareClass3 2024-03-31 13062468 bus:OrdinaryShareClass4 2025-03-31 13062468 bus:OrdinaryShareClass4 2024-03-31 13062468 bus:AllOrdinaryShares 2025-03-31 13062468 bus:AllOrdinaryShares 2024-03-31 13062468 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 13062468 bus:FRS102 2024-04-01 2025-03-31 13062468 bus:Audited 2024-04-01 2025-03-31 13062468 bus:FullAccounts 2024-04-01 2025-03-31 xbrli:pure xbrli:shares iso4217:GBP